ArticleJournal of translational medicine2014

Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.

Takumi Kumai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.